Skip to main content
The Hebrew University of Jerusalem, Home page
Dr. Sara Eyal

Dr. Sara Eyal

Personalized treatment of epilepsy

Institute for Drug Research, Ein Kerem 613 bld 21 floor 6

  • Home
  • People
  • CALENDAR
  • Publications
  • ACTIVITES
  • Gallery
  • NEWS
  • Links
accessibility
  • Toggle Increase Font Size
    text_fields
  • Toggle Grayscale
    format_color_reset
  • Toggle Negative Contrast
    invert_colors
  • Toggle High Contrast
    contrast
  • Toggle Light Background
    light_mode
  • Toggle Highlight Links
    links
  • Toggle Readable Font
    title
  • Reset
    restart_alt
check

CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance.

Citation:

AJ Claessens, Risler, LJ , Eyal, S, Shen, DD , Easterling, TR , and Hebert, MF . 2010. “Cyp2D6 Mediates 4-Hydroxylation Of Clonidine In Vitro: Implication For Pregnancy-Induced Changes In Clonidine Clearance.”. Drug Metab Dispos, 38, Pp. 1393-6.
Download Citation
  • BibTeX
  • RTF
  • RIS
  • RTF
  • RIS

Recent Publications

  • Causative drugs of Stevens-Johnson syndrome and toxic epidermal necrolysis in Israel.
  • Controlled release of artemisone for the treatment of experimental cerebral malaria.
  • Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green.
  • Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations.
  • Utilization of antiepileptic drugs in Israel.
  • Evaluation of near infrared dyes as markers of P-glycoprotein activity in tumors.
More
The Hebrew University of Jerusalem, Home page
  • ©The Hebrew University of Jerusalem. All Rights Reserved
  • Last update: Jul 2025
  • Terms of Use
  • Accessibility
Admin Login

The Hebrew University websites utilize cookies to enhance user experience and analyze site usage. By continuing to browse these sites, you consent to our use of cookies.